Complementation of two related tumour cell classes during experimental metastasis tagged with different histochemical marker genes. by Lin, W. C. et al.
Br J.Cne 19) 7 1-2 ©McilnPesLd,19
Complementation of two related tumour cell classes during experimental
metastasis tagged with different histochemical marker genes*
W.-C. Lin, K.L. O'Connor & L.A. Culp
Department ofMolecular Biology and Microbiology, Case Western Reserve University, School ofMedicine, Cleveland, Ohio
44106, USA.
Summary Intercellular complementation during tumour development and metastasis was analysed for two
different oncogene (ras or sis) transformants of Balb/c 3T3 cells, tagged with different histochemical marker
genes (lacZ or ALP to generate LZEJ or APSI cells, respectively), by localising them after their co-injection
with specific double-staining protocols. This model evaluates whether limited progression of each tumour class
can be facilitated reciprocally during co-localisation and co-growth in nude mice by taking advantage of the
sensitivity of the histochemical marker genes for localising them. After intravenous co-injection of equal
numbers of both cells to analyse experimental metastasis, most foci transiently established in the lung for
several hours were comprised of only one cell class. However, a significant fraction of foci contained both cell
types, as identified in double-stained whole-lung tissues and in lung sections. Evidence was obtained that LZEJ
cells increase the survivability and subsequent growth of APSI-containing micrometastases during co-
localisation in lung, when compared to APSI cells injected alone. Conversely, APSI cells facilitate expansion of
LZEJ cells from micrometastatic foci into overt-metastatic nodules in the lung. These analyses reveal
reciprocity during experimental metastasis by two related tumour cell classes derived from the same parental
cell.
The ras oncogene conveys some metastatic competence to
tumour cells in a large number of biological systems (Bar-
bacid, 1987; Egan et al., 1987; Fidler & Balch, 1987; Hart et
al., 1989; Hart & Saini, 1992; Miller & Heppner, 1990;
Nicolson, 1988). In previous studies from this laboratory
(Radinsky & Culp, 1991; Radinsky et al., 1987), it was
shown that Kirsten murine sarcoma virus-transformed Balb/c
3T3 cells could form pulmonary micrometastases in athymic
nude mice but overt metastases could be detected rarely, with
the clonal dominance of very select cell types within the
Ki-ras-transformed cell population during tumour progres-
sion (Radinsky & Culp, 1991). These results suggested that
the primary effect of ras in a Balb/c 3T3 recipient was the
promotion of escape of selected cells from the primary
tumour site and their subsequent invasion of a target organ
but not efficient outgrowth, indicating again that other
growth-promoting genes are required for complete metastatic
expansion. These requirements might include any host organ-
specific growth factor (Cavanaugh & Nicholson, 1989), as
well as growth factors supplied by the tumour cells them-
selves (Goustin et al., 1986; Hart et al., 1989; Hart & Saini,
1992). In the experiments reported here, we test a model for
the paradigm in which two different tumour cell classes,
highly related to each other genetically but expressing differ-
ent genes potentially important for complete metastasis, arise
during tumour development from the same parental cell.
These two classes of tumour cells would then facilitate pro-
gression for each other at discrete stages of metastasis.
In order to follow the fates of human EJ-ras-transformed
Balb/c 3T3 cells more effectively in situ both qualitatively and
quantitatively, we used the bacterial lacZ marker gene to tag
ras-transformed 3T3 (LZEJ**, abbreviation for LacZ/EJ-Ha-
ras-expressing cells), permitting their detection as blue-stain-
ing single cells minutes-to-weeks after injection (Lin et al.,
1990a). Ultrasensitive detection of the lacZ marker gene
enables us to follow the earliest stages of development of
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micrometastatic foci at target organs and to quantitate the
metastatic potential of LZEJ cells more accurately (Lin et al.,
1990a,b). The micrometastasis pattern in this LZEJ system
with plasmid-transfected EJ-Ha-ras oncogene is very similar
to that observed in the viral Kirsten-ras transformation
system, suggesting again that the ras oncogene may effect
stable invasion of the lung by a small subset of 'transformed'
Balb/c 3T3 cells and that only a very small subset of these
become successful at forming overt metastases (Lin & Culp,
1992a; Lin et al., 1990a,b). Therefore, growth and population
expansion of micrometastatic cells at target organs are limit-
ed, except in a few exceptional cases.
Heterogeneity of tumour cell subpopulations and their
cooperation in contributing to malignant tumour progression
have been studied in only a few systems (Aslakson et al.,
1991; Hart & Saini, 1992; Heppner & Miller, 1983; Magha-
zachi et al., 1988; Miller et al., 1980; Miller & Heppner,
1990). Interactions among subpopulations of tumour cells
could very well determine the outcome of metastasis (Hart et
al., 1989; Miller & Heppner, 1990). To investigate the
requirements for maximising/minimising tumour progression
in the studies described herein, parental Balb/c 3T3 cells (not
harbouring the ras oncogene) were transfected with another
oncogene whose product may complement the activities of
ras-transformed 3T3 cells by intercellular mechanisms - the
sis oncogene, whose PDGF growth factor product (PDGF
B-chain) stimulates growth of 3T3 cells and their derivatives.
Sis has been shown competent for transforming Balb/c 3T3
cells (Sugita et al., 1992; Westermark & Heldin, 1991; Zhan
& Goldfarb, 1986). Since proliferation of parental and deri-
vative Balb/c 3T3 cells is dependent on exogeneous PDGF,
PDGF production by a second cell class may facilitate
growth of ras-transformed micrometastatic cells in the lung
and facilitate tumour progression. Conversely, ras-trans-
formed cells may provide factors or microenvironments that
facilitate progression of the sis transformed cells. To analyse
these possibilities, human c-sis-transfected 3T3 cells were tag-
ged with a second histochemical marker gene (human placen-
tal alkaline phosphatase [Lin & Culp, 1991]) in order to
examine the 'trans' complementation of two related tumour
cell types, one containing ras and the other sis.
Materials and methods
The following experimental materials were obtained from
commercial sources: tissue culture flasks and multiple-well
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dishes from Becton Dickinson Labware, Oxnard, CA; neo-
natal calf serum from Biologos Co., Naperville, IL; Per-
mount, acetone, formaldehyde, and microscope slides from
Fisher Scientific Co., Fairlawn, NJ; Dulbecco's modified
Eagle's medium (DMEM) and G418 sulfate from Gibco Co.,
Grand Island, NY; glutaraldehyde from Eastman Kodak
Co., Rochester, NY; glycol methacrylate embedding kit (JB-
4) from Polysciences, Inc., Warrington, PA; HEPES, RNase
A, naphthol AS-BI phosphate, fast red TR, neutral red,
methyl green, potassium ferricyanide, potassium ferrocya-
nide, and paraformaldehyde from Sigma Chemical Co., St.
Louis, MO; 5-bromo-4-chloro-3-indoyl-p-D-galactopyranoside
(X-gal), 6-chloro-3-indoyl-p-D-galactopyranoside (Red-gal),
5-bromo-4-chloro-3-indoyl phosphate (X-phosphate), p-nitro
blue tetrazolium chloride (NBT) from Research Organics,
Cleveland, OH.
Cell culture and transfection
All cell lines were free of Mycoplasma and grown in Dul-
becco's modified Eagle's medium with 250 units ml-' penicil-
lin, 250 ftgml-' streptomycin sulfate, and 10% newborn
bovine serum. The generation of the tumour-progressing
LZEJ clone (abbreviation for LacZ- and human EJ-Ha-ras-
expressing cells) by transfection of Balb/c 3T3 (clone A31)
cells, as well as the genetics and expressions of the human
EJ-Ha-ras, neomycinR, and lacZ genes in this clone after
transfection, have been described previously (Lin et al.,
1990a). Marker gene expression was stable during one round
of tumour progression in nude mice, but was frequently lost
during a second round of passage of tumour cell populations
(Lin et al., 1990a; Lin & Culp, 1992a).
To generate sis oncogene-transformed cells containing a
second histochemical marker gene, the pRSVPAP and pREP-
Isis plasmids were transfected into Balb/c 3T3 (clone A31)
cells by the calcium phosphate precipitation technique. The
human tumour origin and activity of this c-sis gene, coding
for the B chain of PDGF, have been described previously
(Beckmann et al., 1988), including its ability to transform
3T3 cells (Sugita et al., 1992; Zhan & Goldfarb, 1986). The
generation and activity ofthe pRSVPAP plasmid in 3T3 cells
has also been described (Lin & Culp, 1991). This plasmid
expresses the human placental alkaline phosphatase (ALP)
gene using several different substrates to generate different
coloured products in transfected cells (Lin et al., 1992). After
G418 selection of transfectants and their outgrowth in soft
agar, two clones were selected for these studies based on
excellent histochemical staining - clone APSI (abbreviation
for Alkaline Phosphatase- and SIs-expressing cell) and clone
APB. APSI cells express high levels of human c-sis mRNA,
as determined on northern blots, while APB cells express
amounts of c-sis mRNA that are below detection by north-
ern analysis; both clones stain intensely when assayed for
human ALP activity (Lin et al., 1992).
Animals and tumour cell inoculation
Animals were maintained pathogen-free in the Athymic
Animal Facility (Case Western Reserve University Cancer
Center). For individual injections, LZEJ or APSI cells (I x
105 cells/0.2ml PBS suspended to guarantee single cells as
verified by plating cells into culture dishes) were inoculated
intravenously into 6 to 8 week old female athymic nude mice
(HSD nu/nu). After sacrifice of animals at the indicated
times, lungs were removed for evaluation of tumour cell
distribution by histochemical staining as specified below.
P-Galactosidase staining
Tissue cultured cells were rinsed with PBS and fixed for
5 min at 4°C with 2% (v/v) formaldehyde, 0.2% (v/v) gluta-
raldehyde in PBS. The fixed cells were rinsed with PBS three
times and then incubated at 37°C overnight in stain solution
containing 1 mgml-1 X-gal to stain cells blue (or Red-gal as
indicated to stain cells red (Lin et al., 1992)), 20mM potas-
sium ferricyanide, 20 mm potassium ferrocyanide, and 2 mM
MgCl2 in PBS. For whole-organ staining, selected organs
were removed from animals immediately after sacrifice. After
fixation in 2% (v/v) formaldehyde, 0.2% (v/v) glutaraldehyde
in PBS for 60min, these organs were rinsed with PBS three
times and incubated in the X-gal staining solution. Nonidet-
P40 and sodium deoxycholate were added to the stain solu-
tion to final concentrations of 0.02% (v/v) and 0.01% (w/v),
respectively. After incubation at 4°C overnight, the tissues
were rinsed briefly with 3% (v/v) dimethyl sulfoxide in PBS
and then with PBS (Lin et al., 1990a). Samples were stored at
4°C in 0.02% (w/v) sodium azide in PBS before microscopic
evaluation and photography.
Alkalinephosphatase staining
Tumour cells bearing the human ALP marker gene were
detected by histochemical staining in order to differentiate
them from lacZ-bearing tumour cells (Lin et al., 1992). Cul-
tured APSI cells were fixed for 5 min at 4°C with 2% (v/v)
formaldehyde, 0.2% (v/v) glutaraldehyde in PBS, rinsed with
PBS three times, and incubated at 37°C or 4°C for 30min
with 1 mg ml-' X-phosphate, 1 mgml-' NBT in pH 10.0,
0.1 M Tris buffer to stain cells reddish-black; to stain them
blue, cells were treated with X-phosphate without NBT (Lin
et al., 1992). Cells were rinsed with PBS and stored at 4°C in
0.02% (w/v) sodium azide in PBS.
For whole-organ staining to detect ALP activity, tissues
were rinsed with PBS, fixed for 60 min at 4'C with 2% (v/v)
formaldehyde, 0.2% (v/v) glutaraldehyde in PBS, heated at
65°C for 30 min, rinsed with PBS three times, and incubated
at 4C overnight with 1 mg ml-' X-phosphate, 1 mg ml-I
NBT, 0.02% NP-40, 0.01% sodium deoxycholate in 0.1 M
Tris buffer pH 10.0 to stain tumour cells reddish-black (alter-
natively, with X-phosphate without NBT to stain them blue).
The 65°C heating step is critical to inactivate any host tissue
and blood vessel alkaline phosphatase activity, while conserv-
ing the activity of the transfected placental form of alkaline
phosphatase which is resistant to this heat treatment (Hen-
thorn et al., 1988). After staining, tissues were rinsed with
PBS and stored at 4'C in 0.02% (w/v) sodium azide in PBS.
Analysis oftissue sections
To evaluate in some detail the locations of the two tumour
cell classes, tissues previously stained for lacZ and/or for
ALP gene activities (described above) were cut into 4-ltm
thick sections after embedding in methacrylate as described
previously (Lin et al., 1990a). They were also counterstained
with neutral red in order to improve resolution of the host
cells with the two tumour cell classes.
Photomicrography
Photomicrographs of sections and cultured cells were obtain-
ed with a Nikon Diaphot-TMD microscope equipped with a
Microflex AFX. Photomicrographs of whole organs were
obtained with a Nikon SMZU dissecting microscope equip-
ped with a Microflex UFX.
Results
Double-staining analyses ofmixed cellpopulations
Double-staining protocols are used to resolve two tumour
cell classes tagged with different histochemical marker genes
(Lin & Culp, 1991; Lin et al., 1992). The naphthol-ASBI (or
naphthol-ASMX)/fast red protocols for alkaline phosphatase
activity are unsuitable for whole-organ staining to detect
ALP-tagged tumour cells because of high background stain-
ing of blood vessels and some organ cells. The X-phosphate/
NBT protocol described in this study is far more sensitive for
cell detection and can be used for whole-organ staining upon
heat treatment to reduce background staining. This results in912 W. LIN et al. ......\.c;.}.-oi||...................................................
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Figure 1 Short-term fate of APSI cells in the lung after i.v. injection. APSI tumour cells were detected after staining of the whole
lung with the X-phosphate/NBT combination. a, A lung from a mouse given an i.v. injection of I x lOs APSI cells, 1 h
post-injection. Reddish-black staining microfoci are numerous, a few of which are indicated by white arrowheads (Magnification,
20 x). b, A lung from a mouse at higher magnification, 1 h post-injection. Blood vessel structures, indicated by black arrows, are
apparent because of the persistence of red blood cells (Magnification, 100 x). Most microfoci become localised at the ends of the
smallest blood vessels in the lung. c, A lung from a mouse at low magnification, 24 h post-injection. Reddish-black staining APSI
microfoci are far fewer in number than at early time points (compare with a) and are indicated by white arrowheads
(Magnification, 20 x).INTERCELLULAR COMPLEMENTATION AND TUMOUR PROGRESSION 913
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Table I Quantitation of pulmonary micrometastases/nodulesa
APSI injected singly APSI Co-injected with LZEJ
Time of Micro- Staining Non-staining Double LZEJ APSI non-staining double
sacrifice metastases nodulesf nodulesc stainingfocid nodules' nodules' nodules' staining nodules'
I h 2,500-3,000 (100) 0 0 500 (100) 0 0 0 0
6 h 700 (28-23) 0 0 122 (24) 0 0 0 0
24 h 104 (4.2-3.5) 0 0 24 (5) 0 0 0 0
3 weeks 38 (1.5-1.3) 10 0 3 (0.6) 26 20 7 3
5 weeks 37 (1.5-1.2) 54 17 NDe NDe NDe NDe NDe
7 weeks 8 (0.3) 10 5 NDe NDe NDe NDe NDe
aMice (24fortwo separate experiments) were given i.v. injectionsof 1 x 105 APSI cells alone or asa mixturewith 1 x I05 LZEJ
cells as indicated. At various times post-injection, mice were sacrificed; whole lungs removed, rinsed with PBS and stained with
X-phosphate (or sequentially with X-gal and then with X-phosphate/NBT in the case ofco-injections ofLZEJ and APSI cells).
These values for 1 x 105 LZEJ cells injected alone have been published previously (Lin et al., 1990b). bValues = Number of
micrometastases determinedwiththeuseofadissectingmicroscope. Valuesinparenthesesrepresent thenumberoffoci remaining
inthelungasapercentofthe 1 hvalue. CDenotes nodulesofconsiderable size(>100cells). Nodules which wereheterogeneous in
their staining for the histochemical marker genes are referred to as non-staining nodules. dThese are the number of
micrometastases containing both LZEJ and APSI cells in co-localised foci. Values in parentheses represent the number of foci
remaininginthe lungasapercentofthe 1 hvalue. Themaximal numberoffoci ofall cell classes (LZEJ-only plus APSI-only plus
co-localised foci) observed at any time point was 6-7,000. 'Not determined.
intense reddish-black staining of APSI cells in culture or
organs; alternatively, use of X-phosphate alone (without
NBT) results in blue staining of APSI cells (Lin et al., 1992).
It should be noted that X-gal (or Red-gal) treatment ofAPSI
cells failed to stain them at all; similarly, X-phosphate
(± NBT co-substrate) treatment of LZEJ cells failed to stain
them (data not shown), demonstrating specificity ofthe histo-
chemical substrate for the respective marker gene-coded
enzymes (Lin et al., 1992). For mixtures of LZEJ and APSI
cells in vitro or in vivo, it is critical that the X-gal (or
Red-gal) staining be performed first because of the heat
sensitivity ofthe bacterial enzyme; cells or tissues can then be
heat-treated at 65°C to eliminate host tissue alkaline phos-
phatase activity for subsequent staining with X-phosphate ±
NBT to identify APSI tumour cells.
Tumourprogression ofAPSI cells
It was first essential to define the tumorigenic and metastatic
potential of the APSI cells (in the absence of any other cell
type) when they were injected into nude mice. The latency of
APSI primary tumour development at subcutaneous sites is
approximately 20 days - longer than LZEJ primary tumour
latency (14 days). Of note, no micrometastases were ever
observed in the lungs of animals when APSI cells were
injected s.c., while micrometastases of LZEJ cells were read-
ily detectable after s.c. injection (Lin et al., 1990a,b).
Therefore, primary tumorigenicity and metastatic potential of
sis-transformed Balb/c 3T3 cells are much poorer than those
of ras-transformed 3T3 cells.
The fate of APSI cells in the lungs after i.v. injection was
explored for comparison with LZEJ cells reported previously
(Lin et al., 1990b). Kinetics of clearance of APSI cells within
24 h are slightly different from those of LZEJ cells. As shown
in Figure la and Table I, APSI cells populated the lung in
large numbers during the first several hours, numbers similar
to those observed with LZEJ cells (Lin et al., 1990b). At
higher magnification (Figure Ib), it becomes apparent that
these APSI microfoci have established themselves at the ends
of very small blood vessels identified by persistence of hemo-
globin-containing cells and by their branching networks.
Clearance of most APSI microfoci from the lung has occur-
red by 6 h (Table I), a rate which differs from LZEJ clear-
ance where the number ofmicrofoci remains high from 5 min
to >6 h (Lin et al., 1990b). APSI focus clearance continues
between 6 and 24 h when a baseline of foci become esta-
blished (white arrowheads in Figure lc). Some of these per-
sist for several weeks as micrometastases and some grow into
sizeable metastatic nodules (Table I).
Complexity of clonal evolution of APSI tumour cell vari-
ants during experimental metastasis is documented more fully
in Figure 2. Five weeks after i.v. injection, most APSI micro-
foci persist as small micrometastases with uniform staining
for the ALP marker gene (Figure 2a and b). As a few
nodules develop (Figure 2c), it becomes apparent that some
intense-staining APSI cells grow clonally in localised regions
of the nodule while ALP- (i.e. non-expressing) variants are
generated in other localised regions. This is more evident in
larger nodules (Figure 2d, e and f) where ALP- variants
overgrow ALP' cells and become the dominant cell type in
some nodules. Since APSI cells were cloned and were homo-
geneously staining for the ALP marker gene during their in
vitro history, these results indicate that ALP- variants arise
during cell division processes in vivo and that some of these
variants may have selective advantage in forming larger lung
nodules for any one of a number of reasons.
Co-development ofAPSI and/or LZEJfoci during
experimental metastasis
LZEJ and APSI cells were then followed after their co-
injection i.v. to evaluate any cooperative interaction between
these two related tumour cell types during establishment
clearance, and nodule development in the lung. Two different
Figure 2 Staining for alkaline phosphatase activity in lungs to detect experimental micro/metastases at later time points. Whole
lungs from animals given an i.v. injection of I x 105 APSI cells were fixed and stained at the indicated time points (later than those
of Figure 1) for ALP gene activity using the X-phosphate/NBT combination. a, Reddish-black-staining micrometastatic foci, whose
size and morphology compare with those at the earliest time points, can still be identified at 5 weeks post-injection (Magnification,
100 x). b, A small micrometastatic focus of stainable tumour cells at the edge of the lung where a larger metastatic nodule is
developing, 5 weeks post-injection (Magnification, 100 x). c, A heterogeneous reddish-black staining small nodule is identified, 5
weeks post-injection (Magnification 100 x). This nodule is larger than the metastases shown in a and b and contains several
intensely staining foci of expanding cell numbers, as well as neighbouring regions of tumour cells where stainability is much
weaker. d, A large nodule observed at 3 weeks post-injection illustrates the increasing heterogeneity of tumour cell staining as the
metastatic nodule develops (Magnification, 100 x). There are many intensely staining foci of tumour cells concentrated at the
periphery of the nodule and many non-staining regions which concentrate in the interior of the nodule. e, At lower magnification, a
large heterogeneous reddish-black staining nodule is identified, 5 weeks post-injection (Magnification, 45 x). f, Higher
magnification of panel d (Magnification, 100 x). This illustrates the heterogeneity of ALP' and ALP- foci that contribute to the
expanding metastatic nodule in the lung.INTERCELLULAR COMPLEMENTATION AND TUMOUR PROGRESSION 915
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Figure 3 Distribution of APSI and LZEJ tumour cells in the lung soon after their intravenous co-injection. Lungs were removed
from mice given an i.v. injection of a mixture of I x 10i LZEJ cells and I x 10 APSI cells, 1 h post-injection. Lung were fixed and
stained with Red-gal substrate first; then heat-treated; and finally stained with X-phosphate alone. Red-stained LZEJ foci,
well-isolated from APSI foci, are indicated by black arrowheads; blue-stained APSI foci, well-isolated from LZEJ foci, are
indicated by black arrows. Two double-stained foci, containing both tumour cell types, are also observed at a significant frequency
and are indicated by open arrows. a 100 x. b, 200 x. c, 300 x.916 W. LIN et al.
double-staining regimens - X-gal and X-phosphate/NBT (or
Red-gal and X-phosphate) - were used for maximising reso-
lution of the two tumour cell classes in common environ-
ments, depending upon whether sections or whole organs
respectively were being analysed. In all cases, the two cell
types were mixed thoroughly in a tube prior to injection and
for standardisation to the experiments reported above the
same number of each cell was used for all injections (1 x 105
of each). The tissues were fixed and stained -for P-galacto-
sidase activity first and then heated at 65°C for 30min to
reduce the background staining of lung tissue alkaline phos-
phatase activity (this was verified in control experiments).
Finally, they were stained for alkaline phosphatase activity
expressed from the transfected ALP gene in APSI cells.
As shown in Figure 3a-c at 1 h post-injection, the Red-gal
and X-phosphate combination provided very good contrast
between red-staining LZEJ foci (black arrowheads) and blue-
staining APSI foci (black arrows). While most foci were
homogeneously staining for the marker genes and well-separ-
ated from neighbouring foci, some double-staining foci were
always noted (open arrows in Figure 3a and b), even at
highest magnification (Figure 3c). Therefore, the different
tumour cell classes do undergo some degree ofco-localisation
in the lung after intravenous co-injection (see below as well).
Quantitation of the three classes offoci (APSI-only; LZEJ-
only; co-localised foci) reveals some interesting aspects of
micrometastasis establishment with time. At 1 h post-
injection, more than 500 double-stained foci (6-7% of all
foci) were resolved out of a total number of 6-7,000 foci
a
(Table I). The number of double-staining foci decreased to
122 at 6 h post-injection. By 24 h, 24 double-stained foci
were observed. These are shown in Figure 4 - well-separated
homogeneous foci of LZEJ or APSI cells in most cases
(Figure 4a), foci of the two cell types neighbouring each
other but not intermixing (Figure 4b), and intimately
associated foci of both cell types (Figure 4c and d). When the
percentages of APSI-only and APSI/LZEJ co-foci are com-
pared to the values at the 1 h time point (Table I), it is clear
that the co-localised foci are cleared at approximately the
same rate as the APSI-only foci. This indicates that the
co-localised foci do not necessarily have any stabilising
advantage for the establishment of micrometastases in the
lung.
To evaluate more rigorously whether the two tumour cell
classes 'associate' with each other during micrometastasis,
sections of lung were analysed at these various time points.
Neutral red was used to counter-stain normal lung tissue for
resolution of host organ cells without interfering with the
two histochemical staining reactions for tumour cell identi-
fication. Because of counter-staining, the X-gal (LZEJ cells
stain blue) and X-phosphate/NBT (APSI cells stain reddish-
black) combination was more effective for resolution of the
two tumour cell classes in sections. At 1 h post-injection lung
sections reveal well-separated foci of each class (Figure Sa),
as well as at other time points (Figure 5b,c and d). Further-
more, double-staining foci (open arrows) can be seen readily
at 1 h post-injection (Figure 5b), at 6 h (Figure Sc), and at
24 h (Figure Sd). Furthermore, all foci identified of both cell
C
*:
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Figure 4 Persistent co-localisation of LZEJ/APSI lung microfoci after 24 h. Lungs from mice given an i.v. injection ofa mixture of
1 x iOs LZEJ cells and 1 x 105 APSI cells were recovered at 24 h post-injection, fixed and stained with Red-gal to detect lacZ gene
activity, heat-treated, and finally stained with X-phosphate to detect ALP gene activity after heat-treating the tissue. a, This panel
illustrates that well-isolated and homogeneous microfoci can be detected after labile foci of both cell types have been cleared from
the lungs. Two red-staining LZEJ foci are indicated by black arrowheads and two individual blue-staining APSI foci by black
arrows (Magnification, 100 x). b, A red-staining LZEJ microfocus is seen adjacent to a blue-staining APSI microfocus (Magnifi-
cation, 100 x). c and d show other examples of double-staining microfoci that are readily identified at this time point (both
magnifications, 100x ).INTERCELLULAR COMPLEMENTATION AND TUMOUR PROGRESSION 917
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Figure 5 Lung sections revealing separated and co-localised microfoci soon after co-injection of LZEJ and APSI cells. At the indicated time points, lungs from mice injected i.v. with a mixture of 1 x 105 LZEJ and 1 x 105 APSI cells were stained with X-gal for lacZ activity and then with X-phosphate/NBT for ALP activity after heat treatment. Lungs were then embedded in methacrylate as described in Materials and methods and sections counter-stained with neutral red. Blue-staining LZEJ cells are indicated by black arrowheads and reddish-black staining APSI cells by black arrows. Double-stained foci containing both cell types are indicated by open arrows; the intimacy of the two tumour cell classes to each other is readily apparent in these sections. a, 1 h post-injection (Magnification, 360 x). b, 1 h post-injection (Magnification, 360 x). c, 6 h post-injection (Magnification, 360 x). d, 24 h post-injection (360 x).
classes contained several cells (usually 2-6 cells) and con-
firms earlier studies of LZEJ for the multi-cellularity of lung
foci (Lin et al., 1990b). Intimate tumour cell: tumour cell
relationships are therefore revealed by histochemical analyses
of lung sections.
Development oflarge metastatic nodules from micrometas-
tases was then evaluated with co-injected populations. The
quantitative data of Table I reveal that a number of the
metastatic nodules during several weeks in the lung contain
both APSI and LZEJ cells. Association of the two cell types
in these expanding nodules is revealed by staining whole
lungs at 3 weeks (Figure 6). Interspersed LZEJ (blue stain-
ing) and APSI (reddish-black staining) cells are apparent in
some nodules (e.g. Figure 6a). In other cases, a large LZEJ
nodule neighbours a small APSI micrometastasis (Figure 6b).
APSI or LZEJ nodules can neighbour each other, but not be
in intimate contact (Figure 6c) while in other cases may be
contacting (Figure 6e). Another example of both cell types
co-growing in a common metastatic nodule is provided in
Figure 6f. Even at this later time, many foci persist as
micrometastases (Figure 6d). These findings reveal that not
all metastases are uniclonal - a significant number are at least biclonal (i.e. containing both LZEJ and APSI cells),
raising the possibility that intercellular cooperation between
the two cell types could facilitate experimental lung metas-
tasis.
This paradigm was extended to two other experiments in
which (a) the two cell classes are injected sequentially with a
small period of time between the two injections or (b) one of
the cell types in culture is replication-inactivated by Mito-
mycin C treatment prior to injection into the animal. Mito-
n,ycin C inhibits cell division while permitting them to stably
express differentiated products as 'feeder layers' for several
weeks in culture (Barofflo et al., 1988; Lin & Culp, 1992b). Mitomycin C-treated cells were shown to be nonviable by their inability to form colonies in culture at low dilutions (data-,not shown).
Cooperation between LZEJ and APSI cells is indicated by the increased numbers of lung nodules in sequentially- injected animals (Table II; compare with APSI-only or APSI/ LZEJ data at 3 weeks in Table I). When 6 h separate the two injections, the number of expanding nodules in the lung remains high for both cell types. This cannot be explained by
a simple mass-action principle because injection of 2 x 105
cells of only APSI or LZEJ does not lead to a doubling of
the number of metastatic nodules (data not shown). More-
over, when APSI cells are first rendered non-dividing with
Mitomycin C (Lin & Culp, 1992b), the number of LZEJ
nodules decreases from 19 to 11 and, as expected, APSI-only nodules become nonexistent. When the inter-injection time is
increased to 7 days, there continues to be some complemen- tation of the two cell types in forming LZEJ nodules; this is
also abolished by treating cells with Mitomycin C prior to injection. Since Mitomycin C-treated APSI cells also implant in the lung for several hours similarly to untreated cells, these
results cannot be explained by improved initiation of micro-
metastasis development for LZEJ cells by APSI cells. Rather, dividing APSI cells are required for facilitation. These data
a918 W. LIN et al.
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Figure 6 Co-development oflung metastases at later time points. At 3 weeks post-injection i.v., lungs were recovered from animals
receiving a mixture of I x 10i LZEJ and I x 10i APSI cells (panels a-e) or of I x 105 LZEJ and I x 105 APB cells (panel f)).
Lungs were fixed and stained with X-gal for lacZ activity and then with X-phosphate/NBT for ALP activity. Blue-staining LZEJ
cells are indicated by black arrowheads; reddish-black staining APSI or APB cells by black arrows. a, A heterogeneous-staining
small nodule contains APSI cells interspersed among more prominent LZEJ cells (Magnification, 100 x). b, A small APSI focus
indicated by a black arrow is observed adjacent to a large blue-staining LZEJ nodule (Magnification, 100 x). c, A blue-staining
LZEJ nodule is observed next to a reddish-black-staining APSI nodule; there does not appear to be any mixing of the two tumour
cell classes in these separated nodules (Magnification, 100 x). d, Two well-separated collections of micrometastatic foci are
indicated (Magnification, 100 x). e, A large APSI nodule, containing highly staining cells in some regions and non-staining cells in
other regions, is abutting a smaller blue-staining LZEJ focus (Magnification, 100 x). f, A heterogeneous-staining nodule contains
both LZEJ and APB cells, while a nearby small nodule contains only APB cells (Magnification, 100 x). Note that in the large
nodule the APSI cells tend to concentrate at the periphery of the nodule while the LZEJ cells concentrate in the central region.INTERCELLULAR COMPLEMENTATION AND TUMOUR PROGRESSION
Table II Quantitation of metastasis formation by sequential injections of LZEJ/APSI cellsa
Time of Lung Metastatic Nodules
Injection protocol sacrifice LZEJ-stained APSI-stained Non-stained
LZEJ - 6 h - APSI 3 weeks I9c (l)d I9c (1)d 6c
LZEJ - 6 h - APSI (Mitomycin C)b 3 weeks 1IC OC 3c
LZEJ - 7 days - APSI 3 weeks 19C 0c 3c
LZEJ -7 days - APSI (Mitomycin C)b 3 weeks 8c 6c
aMice (two for each datum value) were given i.v. injections of 1 x 105 LZEJ cells first, followed by the
indicated time span with 1 x 105 APSI cells. Threeweeks post-injection, mice were sacrificed. Whole lungs
were removed, rinsed well with PBS, and stained withX-gal andX-phosphate/NBT forenumeration ofthe
metastaticnodulesdetectedinthelungs. Inmostcases,thenoduleswerehomogeneouslystainedforonlyone
marker gene, with the exception ofdouble-staining nodules shown in parentheses. In a few cases, nodules
contained segments that were stained for one of the marker genes and neighbouring segments that were
unstained (non-stained). "APSI cells were treated with 5 Itgml-' Mitomycin C in culture (prior to their
injection intoanimals)for 16 hinordertopreventanycelldoublingwhilemaintainingtheirabilitytoexpress
the marker gene and other differentiation genes. CNumber of foci (stained or unstained as indicated) per
mouse per entire lung when all three lobes were analysed in this group. d(#) = double stained nodules,
containing both LZEJ and APSI cells co-localised in the same nodule.
suggest that stability/expandability of LZEJ pulmonary
microfoci occurs many hours-to-days following their injection
and that live APSI cells contribute environmental cues that
improve these processes for LZEJ cells.
Discussion
These analyses demonstrate the effectiveness of using two
different histochemical marker genes to tag two different, but
related (both being oncogene derivatives of clone A31 Balb/c
3T3 cells), tumour cell classes in situ and to evaluate whether
the two classes alter the tumour progression characteristics of
each other. They support the concept of multiple clonal
interactions during tumour progression (Heppner, 1984; Hart
& Saini, 1992). Evidence has been obtained for the pheno-
typic/genotypic heterogeneity of breast carcinoma tumour
populations in animal model systems, as well as evidence for
cooperativity among multiple subpopulations in the breast
tumour system (Miller et al., 1980, 1988). However, little
study has addressed these possibilities in other tumour
systems of human or animal origin. The approach described
herein can be used for any two or three related tumour cell
classes by transfecting different histochemical maker genes
into each class to permit their precise identification in com-
plex environments at the single-cell level. Each class could be
generated by transfecting different oncogenes, tumour sup-
pressor genes, or other candidate metastasis genes into a
common parental cell to evaluate their significance during
tumour progression.
Previous studies had demonstrated the utility of the bacter-
ial LacZ gene for tracking EJ-Ha-ras-transformed Balb/c 3T3
cells during progression (Lin & Culp, 1992a; Lin et al.,
1990a,b). The current experiments illustrate the same utility
and specificity of the human placental alkaline phosphatase
gene (Lin & Culp, 1991), transfected into c-sis transformed
3T3 cells, for tracking APSI cells. With two different com-
binations (X-phosphate alone to stain cells blue or X-phos-
phate plus the cofactor NBT to stain them reddish-black),
APSI cells stained intensely and selectively, with minimal
staining of untagged 3T3, host organ cells, or LZEJ cells in
vitro or in situ. Furthermore, double-staining protocols were
effective for discriminating mixed populations of the two cell
classes in culture, in whole organ preparations, or in organ
sections.
APSI cells were less tumorigenic than LZEJ cells, display-
ing a longer latency of primary tumour development after
subcutaneous injection and an inability to metastasise to the
lung. The fate ofAPSI cells was also followed during the first
24 h after intravenous injection, since this is the critical
period for establishment and/or clearance of many tumour
cells during experimental metastasis (Fidler & Balch, 1987;
Nicholson, 1988), as also shown for tumour cell LZEJ (Lin et
al., 1990b). The kinetics of APSI clearance differed somewhat
from those of LZEJ - the vast majority of APSI cells were
cleared within the first 6 h while a sizeable fraction of LZEJ
cells were cleared after this, but prior to the basal level
observed at 24 h. APSI micrometastases that became esta-
blished by 24 h appeared to localise at the ends of the
smallest blood vessels in the lung and were always comprised
of 2-6 cells. Therefore, multi-cellularity of lung foci occurs
for 3T3 cells transfected with two different oncogenes. Blood
vessels in lung can be detected by a longer period of fixation
prior to histochemical staining, facilitating retention of
hemoglobin-containing cells. Some APSI micrometastases
expanded into nodules, some of which stained homogeneous-
ly for ALP gene activity and some of which were hetero-
geneous in their staining because of ALP- variants. The
basis for loss of marker gene expression in variants remains
for exploration; this property may prove useful for quanti-
tating the complex evolution of clonal variants during
tumour progression (Lin & Culp, 1992a). The complexity of
clonal evolution of tumours is indicated with studies using
random integration into human tumour cell DNA of drug
resistance genes in experimental animal systems (Moffett et
al., 1992).
When LZEJ and APSI cells were co-injected intravenously,
several pieces of evidence suggest that there may be facilita-
tion of experimental metastasis by these two cell types. First,
a significant fraction of the two cell types co-localise into foci
at all time points providing opportunity for them to interact
intimately in these tissue sites. This was confirmed by stain-
ing sections of lung for the two marker genes. Second, these
foci persist in relative proportion to APSI-only or LZEJ-only
foci from 1 h to several weeks post-injection, indicating that
these co-localised foci are not selected for/against during the
clearance/establishment events. Since APSI foci are cleared
from the lung more efficiently than LZEJ foci after single
injections, these results suggest that LZEJ cells may assist the
survivability of APSI cells in the lung as a result of co-
localisation. Third, the number of APSI-containing metasta-
tic nodules increases when the two cell types are co-injected,
when compared to APSI cells injected alone. This argues that
LZEJ cells promote the metastatic competence of APSI cells,
a concept which is also supported by evidence for both cell
types being in a significant number of larger nodules (5-
10%). Therefore, a significant fraction of lung metastases
have a biclonal origin as a result of coordinate growth of
both cell types in the same nodules; whether this provides
further metastatic aggression and poorer survival for the
animal remains to be determined. Fourth, sequential injection
experiments also led to a doubling of nodules at 3 weeks
containing APSI cells, when compared to the number of
nodules when APSI cells were injected alone. Finally, when
Mitomycin C-treated APSI cells were co-injected with live
LZEJ cells, the number of lung nodules at 3 weeks post-
injection containing LZEJ cells decreased by half. This result
indicates that APSI cells can also promote metastatic com-
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petence of LZEJ cells, but only as a population of dividing
cells. All of these data support a model of intercellular and
reciprocal cooperation between the two tumour cell classes,
both of which are derived from the same parent cell. They
also support the hypothesis that two (or more) cell variants
can be generated during 'natural' tumour expansion and that
these variants might interact to promote tumour progression.
Although it is possible that PDGF produced by APSI cells
may assist cell division of LZEJ cells, other molecular mech-
anisms must be tested as well. This is particularly relevant
from indications that LZEJ cells facilitate progression of
APSI cells. In this regard, there are several documented cases
where growth factors - e.g. PDGF - promote tumour pro-
gression by a paracrine mechanism (Breillout et al., 1989;
Bronzert et al., 1987; Egan et al., 1990; Frazier et al., 1988;
Tsuruo et al., 1989). Sis-oncogene-transformed cells secrete
PDGF that stimulates division of neighbouring cells in a
paracrine fashion (Johnson et al., 1985), in addition to auto-
crine growth stimulation of transformed cells themselves
(Keating & Williams, 1988). PDGF may have regulatory
influence in other steps of tumour progression - during
wound healing processes subsequent to invasion by micro-
metastatic cells; during activation of macrophages/monocytes
during invasion/repair; and during vasoconstriction mediated
by PDGF. Whether LZEJ cells secrete some soluble growth
factor to promote expansion of APSI-containing micrometa-
stases or whether they generate extracellular matrix products
or some other product for this facilitation remains for future
investigation.
Cooperation between cis-acting oncogenes (i.e. acting with-
in the same cell) has been demonstrated in many systems. A
nuclear-acting oncogene (e.g. myc) complements the activity
of a cytoplasmic-acting oncogene (e.g. ras) to generate full
metastatic competence (Weinberg, 1985). In some tumour
progression studies, certain combinations of oncogenes sup-
press the metastatic phenotype (e.g. adenovirus Ela and ras)
(Pozzatti et al., 1988). The use of alternative histochemical
marker genes now permits more careful evaluation of the
significance for tumour progression of two related cell types
whose gene products may act in trans. They will also permit
testing of possible cooperation and/or inhibition between two
cell types containing other classes of genes suspected of being
critical for tumour progression.
The authors extend appreciation to Drs Theresa and Thomas Pret-
low of the Department of Pathology, as well as Mary Ann O'Rior-
dan of their laboratory, for assistance with histological analyses of
sections and staining protocols.
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